Salivary Gland Adenocarcinoma
3 clinical trials · Condition
◉ Watch Salivary Gland Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer (NCT00126607) | National Cancer Institute (NCI) | 2005-07-01 |
| Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers (NCT00095563) | National Cancer Institute (NCI) | 2004-09-01 |
| Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer (NCT00028496) | National Cancer Institute (NCI) | 2001-11-01 |
Track Salivary Gland Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.